Further studies are required to compare the clinical manifestations and cellular responses to IL-10, IL-22, IL-26, and IFN-λ1 of patients with IL-10RB deficiency, with or without fulminant viral hepatitis. This evidence concerns the gene IFNL1 and fulminant viral hepatitis.